Parametrica Management LTD Horizon Therapeutics Public LTD CO Transaction History

Parametrica Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$79.4 - $116.36 $151,415 - $221,898	1,907 Added 57.35%	5,232 $418,000
Q1 2022 May 10, 2022	BUY	$86.42 - $109.81 $287,346 - $365,118	3,325 New	3,325 $350,000
Q2 2021 Aug 13, 2021	SELL	$86.24 - $95.92 $407,828 - $453,605	-4,729 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$71.83 - $95.48 $339,684 - $451,524	4,729 New	4,729 $413,000
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $242,540 - $305,491	-3,620 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $199,932 - $289,346	3,620 New	3,620 $281,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.